Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Products > Novel inhibitors

2'-Deoxyadenosine monohydrate

  Cat. No.:  DC20158   Featured
Chemical Structure
16373-93-6
For research use only. We do not sell to patients.
We match the best price and quality on market.
Email:order@dcchemicals.com  sales@dcchemicals.com
Tel:+86-021-58447131
Get Quotation Now
We are official vendor of:
  • 20
  • 19
  • 18
  • 17
  • 16
  • 15
  • 14
  • 12
  • 11
  • 10
  • 9
  • 8
  • 13
  • 6
  • 5
  • 4
  • 3
  • 2
  • 1
More than 5000 active chemicals with high quality for research!
Field of application
2'-Deoxyadenosine monohydrate is a deoxyribonucleoside. A building block in the chemical synthesis.
Chemicals PropertiesBiological activity COA & MSDSRelated productsDatasheet
Cas No.: 16373-93-6
Chemical Name: 2'-deoxy-adenosine;hydrate
Synonyms: (2R,3S,5R)-5-(6-Amino-9H-purin-9-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol;2-Deoxyadenosine monohydrate;2-deoxyadenosine cell culture tested;Adenine deoxyriboside~9-(2-Deoxy-beta-D-ribofuranosyl)adenine;2-Deoxyadenosine;2'-Deoxyadenosine monohydrate;2'-Deoxyadenosine;2′-Deoxyadenosine hydrate;9-(2-Deoxy-β-D-ribofuranosyl)adenine;Adenine deoxyriboside;2′-Da;Adenyldeoxy;2'-Deoxyadenosine mo;2'-DEOXYADENOSINE:H2O;DEOXYADENOSINE HYDRATE;2'-DEOXYADENOSINE HYDRATE;Deoxyadenosine Monohydrat;2'-Deoxy-adenosine ,98%;2-deoxyadenosine 99-100%;(2R,3S,5R)-5-(6-amino-9H-purin-9-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol hydrate;Adenosine, 2'-deoxy-, monohydrate;SMR000112273;F79D3BS9UH;9-(2-Deoxy-;A-D-ribofuranosyl)adenine;WZJWHIMNXWKNTO-VWZUFWLJSA-N;deoxyadenosine monohydrate;2-deoxyadenosine-monohydrate;MLS000515799;KSC491M3P;MLS0;2'-deoxy-adenosine;hydrate;MLS002695902;CCG-267140;MFCD00149364;16373-93-6;(2R,3S,5R)-5-(6-amino-9H-purin-9-yl)-2-(hydroxymethyl)tetrahydrofuran-3-olhydrate;SCHEMBL431647;J-700308;9-(2-Deoxy-beta-D-ribofuranosyl)adenine;HG1016;AKOS015898954;(2R,3S,5R)-5-(6-amino-9H-purin-9-yl)-2-(hydroxymethyl)oxolan-3-ol hydrate;DS-14579;2?-Deoxyadenosine monohydrate;HY-W011683;HMS2269M24;AC-8211;2 inverted exclamation mark -Deoxyadenosine monohydrate;CS-W012399;CHEMBL1575575;2'-dA;Adenosine, 2'-deoxy-, hydrate (1:1);BP-58685;9-(2'-Deoxy-beta-D-erythro-pentofuranosyl)adenine;DTXSID801036040;2'-Deoxyadenosine Hydrate;UNII-F79D3BS9UH;Deoxyadenosine Hydrate;PD087165;A810506;s9351;(2R,3S,5R)-5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol;hydrate
SMILES: O1[C@]([H])(C([H])([H])O[H])[C@]([H])(C([H])([H])[C@]1([H])N1C([H])=NC2=C(N([H])[H])N=C([H])N=C12)O[H].O([H])[H]
Formula: C10H15N5O4
M.Wt: 269.2572
Purity: >98%
Sotrage: 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
MSDS
COA
LOT NO. DOWNLOAD
2018-0101
Cat. No. Product name Field of application
DC31074 Isopropyl myristate Isopropyl myristate is the ester of isopropyl alcohol and myristic acid.
DC75868 AZ14133346 AZ14133346 (compound 36) is a potent and selective inhibitor of EGFR Exon20 insertions, with the IC50 of 85 nM. AZ14133346 plays an important role in cancer research.
DC75865 TI17 ​​TI17​​ represents a novel class of targeted anticancer agents that specifically disrupt DNA damage repair mechanisms in malignant cells.
DC75816 Nisoxetine Nisoxetine acts as a highly selective and potent noradrenaline transporter (NET) antagonist, exhibiting a binding affinity (Kd) of 0.76 nM. In addition to its antidepressant properties, nisoxetine functions as a local anesthetic by inhibiting voltage-gated sodium channels. This dual pharmacological activity makes it a compound of interest for both neurological and pain management research.
DC75641 GENZ-644282 TFA salt Genz-644282, also known as SAR402674, is a non-camptothecin inhibitor of topoisomerase I with potential antineoplastic activity. Topoisomerase I inhibitor Genz-644282 binds to and inhibits the enzyme topoisomerase I, which may result in the inhibition of repair of single-strand DNA breaks, DNA replication, and tumor cell growth in susceptible tumor cell populations.
DC75325 PSMA-617 TFA PSMA-617, also know as vipivotide tetraxetan, is a ligand used to make 177Lu-PSMA-617, which is a radioactive molecule to fight cancer. PSMA617 possesses a small peptide, which was designed to target prostate-specific membrane antigen (PSMA). PSMA617 demonstrates high radiolytic stability for at least 72 h. PSMA617 has high inhibition potency (equilibrium dissociation constant Ki=2.34±2.94 nM on LNCaP; Ki=0.37±0.21 nM enzymatically determined). 177 Lu-PSMA-617 offers a potential additional life-prolonging treatment option for men with mCRPC.
DC75202 Fosaprepitant free acid Fosaprepitant, also known as MK0517, is an antiemetic drug, administered intravenously. It is a prodrug of aprepitant. Fosaprepitant was developed by Merck & Co. and was approved. It is a prodrug of Aprepitant. It aids in the prevention of acute and delayed nausea and vomiting associated with chemotherapy treatment. Fosaprepitant is a weak inhibitor of CYP3A4, and aprepitant, the active moiety, is a substrate, inhibitor, and inducer of CYP3A4
DC74748 O4I4 O4I4 (compound 23) is a OCT4-inducing compound with metabolical stability.
DC74684 ZH8667 ZH8667 is a trace amine-associated receptor 1 (TAAR1)–Gs agonist.
DC74646 EB-PSMA-617 EB-PSMA-617 is an Evans blue-modified prostate-specific membrane antigen (PSMA) 617 ligand for making 177Lu-EB-PSMA, which is potential useful for Metastatic Castration-Resistant Prostate Cancer.
X
Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.
Site Map|Privacy PolicyCopyright © 2018-2020 All Rights Reserved. Technical Support:KuuJia